InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by GRASSO MARC, Chief Financial Officer. Director active across 1 company, notably Kura Oncology, Inc.. Aggregated, 2 disclosures have been published. History available since 26 January 2022. The latest transaction was filed on 26 January 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
21,900 shares0Common StockSEC:0001209191-22-005391:0
21,900 shares0Common StockSEC:0001209191-22-005391
2 of 2 declarations
About GRASSO MARC
Marc Grasso is the Chief Financial Officer and Chief Business Officer at Kura Oncology, Inc. In these roles, he oversees the financial and business management of the company, ensuring compliance and efficiency in operations.
